Reportlinker Adds Gilead Sciences: PharmaVitae Profile

Dec 08, 2010, 14:09 ET from Reportlinker

NEW YORK, Dec. 8, 2010 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Gilead Sciences: PharmaVitae Profile


This analysis examines the historical and forecast performance for Gilead in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits

Gain insight into Gilead's strategic outlook across the next 6 years

Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source


Strategic insight into the prospects for Gilead over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Your key questions answered

Benchmark Gilead's performance against key rivals in the prescription pharmaceutical sector

Assess the effects of the patent expiry of one of the components of Atripla on the company

See how the launch of two new products, Truvada + rilpivirine and the Quad pill, will generate new growth for the company

To order this report: Gilead Sciences: PharmaVitae Profile

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker